More than 5.1 million seniors and people with disabilities on Medicare saved billions on prescription drugs, thanks to the Patient Protection and Affordable Care Act, according to Department of Health and Human Services secretary Kathleen Sebelius.

Mederma, a maker of scar therapy products, has introduced its new Mederma advanced scar gel, which is designed to reduce the overall appearance of scars caused by injury, acne, surgery or burns with one daily application.

Watson Pharmaceuticals is challenging the patent protection on a drug made by Abbott for treating cholesterol, the company said.

Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension.

Insight Pharmaceuticals has launched a mobile application for its E.P.T. brand.

Many Walgreens customers are "flocking" to independent pharmacies amid the dispute between the retail pharmacy chain and pharmacy benefit manager Express Scripts, a trade group representing the PBM industry said.

Abbott is set to enroll patients into two late-stage clinical trials designed to evaluate the safety and efficacy of one of its drugs as a treatment for a difficult-to-treat chronic inflammatory skin disease.

Amneal Pharmaceuticals has launched a generic version of an antidepressant made by Forest Labs.

The Food and Drug Administration approved an effervescent tablet for treating osteoporosis.

A drug under investigation by Teva Pharmaceutical Industries and Active Biotech reduced symptoms and progression of disease in patients with multiple sclerosis, according to results of a late-stage clinical trial.

Reducing the cutoff of hemoglobin A1C to determine if a patient has prediabetes could be cost effective, according to a new study.

Endo Pharmaceuticals is hoping the Food and Drug Administration will back tougher regulatory approval requirements for generic versions of one of its drugs.